NCT03910387 - Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

October 26, 2023

Study Completion Date

October 1, 2024

Conditions

Locally Advanced Unresectable Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8

Interventions

DRUG

Gemcitabine

Given gemcitabine/nab-paclitaxel combination therapy

DRUG

Nab-paclitaxel

Given gemcitabine/nab-paclitaxel combination therapy

DRUG

Telotristat Ethyl

Given PO

Trial Locations (3)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta